Table 1.
Baseline features of 31 participants and characteristics of the tumor and treatment with106Ru brachytherapy
| Features | |
|---|---|
| Mean Age (median, range-Y) | 51 (55, 22–74) |
| Sex (F) | 18 (56.8%) |
| Mean BCVA (median, range-LogMAR) | 0.71 (0.52, 0.00–3.00) |
| Involved eye (OD) | 20 (62.5%) |
| Mean distance to fovea (median, range-mm) | 3.53 (3.00, 2.00–12.00) |
| Mean distance to optic disc (median, range-mm) | 3.81 (3.00, 0.00–12.00) |
| Mean largest tumor diameter (median, range-mm) | 14.08 (14.00,8.50–21.00) |
| Mean thickness (median, range-mm) | 6.75 (6.70, 2.84–10) |
| Mean foveal dose (median, range-Gy) | 45.76 (11.00, 0.00–501) |
| Mean optic disc dose (median, range-Gy) | 32.91 (13.50, 0.00–266) |
| Mean apex dose (median, range-Gy) | 84.29 (85, 40–100) |